Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (51553) 51553
Book Review (7216) 7216
Publication (2878) 2878
Book / eBook (674) 674
Newsletter (283) 283
Book Chapter (219) 219
Newspaper Article (119) 119
Conference Proceeding (89) 89
Magazine Article (37) 37
Dissertation (35) 35
Government Document (15) 15
Data Set (12) 12
Paper (4) 4
Trade Publication Article (4) 4
Presentation (2) 2
Reference (2) 2
Web Resource (2) 2
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46558) 46558
humans (46290) 46290
female (29273) 29273
male (27956) 27956
surgery (24620) 24620
middle aged (24128) 24128
aged (19874) 19874
adult (16762) 16762
cardiac & cardiovascular systems (15874) 15874
cancer (10906) 10906
abridged index medicus (10219) 10219
medicine & public health (9632) 9632
treatment outcome (9590) 9590
respiratory system (9311) 9311
retrospective studies (7532) 7532
aged, 80 and over (7365) 7365
oncology (7275) 7275
prognosis (6620) 6620
tumors (6501) 6501
vascular surgery (6066) 6066
cardiac surgery (6011) 6011
thoracic surgery (5904) 5904
lung neoplasms - surgery (5225) 5225
abdominal surgery (5079) 5079
risk factors (5017) 5017
metastasis (5014) 5014
vascular endothelial growth factor (5013) 5013
tomography, x-ray computed (4945) 4945
neoplasm staging (4910) 4910
care and treatment (4905) 4905
follow-up studies (4814) 4814
analysis (4449) 4449
carcinoma (4432) 4432
animals (4227) 4227
angiogenesis (4225) 4225
peripheral vascular disease (4057) 4057
survival (3993) 3993
health aspects (3976) 3976
diagnosis (3935) 3935
chemotherapy (3826) 3826
lung neoplasms - pathology (3810) 3810
research (3771) 3771
general surgery (3674) 3674
adolescent (3481) 3481
radiology, nuclear medicine & medical imaging (3421) 3421
immunohistochemistry (3348) 3348
time factors (3297) 3297
survival rate (3129) 3129
cardiothoracic surgery (3059) 3059
mortality (2977) 2977
diagnosis, differential (2956) 2956
management (2884) 2884
expression (2815) 2815
resection (2682) 2682
lung cancer (2665) 2665
magnetic resonance imaging (2629) 2629
therapy (2609) 2609
cardiovascular system (2608) 2608
neoplasm invasiveness (2591) 2591
survival analysis (2577) 2577
patients (2554) 2554
young adult (2446) 2446
endothelial growth-factor (2371) 2371
prospective studies (2364) 2364
lymphatic metastasis (2293) 2293
pathology (2200) 2200
child (2192) 2192
mice (2188) 2188
heart neoplasms - surgery (2164) 2164
cardiology (2120) 2120
risk assessment (2120) 2120
cardiovascular diseases (2073) 2073
cardiology and cardiovascular medicine (2031) 2031
lung neoplasms - mortality (2030) 2030
medicine (2025) 2025
disease-free survival (1978) 1978
breast cancer (1879) 1879
surgical oncology (1877) 1877
cell line, tumor (1868) 1868
pneumonectomy (1840) 1840
vascular endothelial growth factor a - metabolism (1834) 1834
carcinoma, non-small-cell lung - surgery (1796) 1796
recurrence (1788) 1788
adenocarcinoma - surgery (1775) 1775
combined modality therapy (1775) 1775
risk (1769) 1769
complications (1719) 1719
biopsy (1711) 1711
liver neoplasms - surgery (1704) 1704
predictive value of tests (1696) 1696
colorectal cancer (1656) 1656
radiotherapy (1647) 1647
development and progression (1635) 1635
experience (1598) 1598
multivariate analysis (1597) 1597
medical colleges (1596) 1596
neoplasms (1587) 1587
disease (1542) 1542
cardiovascular disease (1539) 1539
oncology, experimental (1535) 1535
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (545) 545
Collection Dvlpm't (Acquisitions) - Closed Orders (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (24) 24
St. Michael's Hospital - Stacks (15) 15
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (13) 13
Humber River Regional Hospital - Church Stacks (11) 11
Scarborough Hospital - General (11) 11
Providence Healthcare - Stacks (9) 9
Humber River Regional Hospital - Finch Stacks (8) 8
Toronto East General Hospital - Stacks (8) 8
Lakeridge Health Sciences - Oshawa (7) 7
Online Resources - Online (7) 7
Trillium Health Centre - Stacks (7) 7
Credit Valley Hospital - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
Providence Healthcare - Reference (5) 5
Scarborough Hospital - Birchmount (5) 5
West Park Healthcare Centre - Stacks (5) 5
Gerstein Science - Circulation Desk (4) 4
UofT at Mississauga - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Markham Stouffville Hospital - Stacks (3) 3
Toronto East General Hospital - Reference (3) 3
Gerstein Science - Missing (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Stacks (2) 2
Providence Healthcare - Reserve desk (2) 2
Scarborough Hospital - Hospital Department (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Earth Sciences (Noranda) - Reference (1) 1
Finch Stacks (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Reference (1) 1
Lakeridge Health Sciences - Online (1) 1
Law (Bora Laskin) - Stacks (1) 1
St Josephs Health Centre - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Lost (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Pharmacy (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
West Park Healthcare Centre - Pharmacy (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51114) 51114
German (525) 525
French (273) 273
Chinese (246) 246
Russian (189) 189
Japanese (181) 181
Spanish (120) 120
Italian (57) 57
Portuguese (53) 53
Polish (47) 47
Hungarian (25) 25
Korean (15) 15
Romanian (15) 15
Czech (13) 13
Turkish (13) 13
Dutch (12) 12
Danish (8) 8
Bulgarian (4) 4
Swedish (4) 4
Croatian (3) 3
Slovak (3) 3
Ukrainian (3) 3
Serbian (2) 2
Arabic (1) 1
Belarusian (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
by De Leyn, Paul and Dooms, Christophe and Kuzdzal, Jaroslaw and Lardinois, Didier and Passlick, Bernward and Rami-Porta, Ramon and Turna, Akif and Schil, Paul Van and Venuta, Frederico and Waller, David and Weder, Walter and Zielinski, Marcin
European Journal of Cardio-Thoracic Surgery, ISSN 1010-7940, 5/2014, Volume 45, Issue 5, pp. 787 - 798
Accurate preoperative staging and restaging of mediastinal lymph nodes in patients with potentially resectable non-small-cell lung cancer (NSCLC) is of... 
Restaging | Preoperative staging | Endoscopic staging | Surgical staging | Lung cancer | SURGERY | REPEAT MEDIASTINOSCOPY | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RANDOMIZED-TRIAL | TRANSBRONCHIAL NEEDLE ASPIRATION | CONVENTIONAL MEDIASTINOSCOPY | ENDOBRONCHIAL ULTRASOUND | CLINICAL FEASIBILITY | INDUCTION THERAPY | RESPIRATORY SYSTEM | VIDEO-ASSISTED MEDIASTINOSCOPY | LYMPHADENECTOMY VAMLA | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - surgery | Lymph Nodes - pathology | Humans | Mediastinal Neoplasms - classification | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - diagnosis | Mediastinal Neoplasms - diagnosis | Neoplasm Staging - methods | Lung Neoplasms - classification | Algorithms | Carcinoma, Non-Small-Cell Lung - classification | Mediastinal Neoplasms - pathology | Lung Neoplasms - surgery | Lung Neoplasms - diagnosis | Mediastinal Neoplasms - surgery | Thoracoscopy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Total pelvic exenteration for primary and recurrent malignancies
by Ferenschild, Floris and Vermaas, Maarten and Verhoef, Kees and Ansink, Anca and Kirkels, Wim and Eggermont, Alexander and Wilt, Johannes
World Journal of Surgery, ISSN 0364-2313, 07/2009, Volume 33, Issue 7, pp. 1502 - 1508
textabstractIntroduction: Complete resection is the most important prognostic factor in surgery for pelvic tumors. In locally advanced and recurrent pelvic... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | SURGERY | CONTINENT URINARY-DIVERSION | MORBIDITY | RESECTION | COLORECTAL-CANCER | INTRAOPERATIVE RADIOTHERAPY | EXPERIENCE | GYNECOLOGICAL MALIGNANCIES | OUTCOMES | ADVANCED RECTAL-CANCER | Endometrial Neoplasms - radiotherapy | Multivariate Analysis | Neoplasm Recurrence, Local - radiotherapy | Prognosis | Endometrial Neoplasms - mortality | Pelvic Exenteration - adverse effects | Humans | Middle Aged | Pelvic Neoplasms - mortality | Male | Uterine Cervical Neoplasms - pathology | Postoperative Complications - mortality | Neoplasm Recurrence, Local - mortality | Hospital Mortality - trends | Neoplasm Recurrence, Local - pathology | Pelvic Neoplasms - radiotherapy | Neoplasm Invasiveness - pathology | Adult | Female | Rectal Neoplasms - pathology | Retrospective Studies | Radiotherapy, Adjuvant | Pelvic Exenteration - methods | Uterine Cervical Neoplasms - mortality | Pelvic Neoplasms - pathology | Pelvic Neoplasms - surgery | Uterine Cervical Neoplasms - radiotherapy | Risk Assessment | Rectal Neoplasms - surgery | Brachytherapy - methods | Kaplan-Meier Estimate | Proportional Hazards Models | Uterine Cervical Neoplasms - surgery | Probability | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Disease-Free Survival | Endometrial Neoplasms - surgery | Survival Analysis | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cohort Studies | Chemotherapy | Sarcoma | Health aspects | Cervical cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
by Norlén, Olov and Stålberg, Peter and Öberg, Kjell and Eriksson, John and Hedberg, Jakob and Hessman, Ola and Janson, Eva Tiensuu and Hellman, Per and Åkerström, Göran and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Gastrointestinalkirurgi and Uppsala universitet and Endokrinkirurgi and Institutionen för medicinska vetenskaper and Institutionen för kirurgiska vetenskaper
World Journal of Surgery, ISSN 0364-2313, 6/2012, Volume 36, Issue 6, pp. 1419 - 1431
Small intestinal neuroendocrine tumors (SI-NETs) are uncommon, with an annual incidence of about 1 per 100,000 individuals. The primary tumor (PT) is generally... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | LIVER METASTASES | SURVIVAL | SURGERY | INTERFERON | MANAGEMENT | NEURO ENDOCRINE TUMORS | PROGNOSTIC-FACTORS | MIDGUT CARCINOID-TUMORS | PERITONEAL CARCINOMATOSIS | COMBINATION | SURGICAL-TREATMENT | Lymph Node Excision | Multivariate Analysis | Prognosis | Follow-Up Studies | Intestine, Small - pathology | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Female | Retrospective Studies | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Neuroendocrine Tumors - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Peritoneal Neoplasms - surgery | Liver Neoplasms - surgery | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Intestine, Small - surgery | Neuroendocrine Tumors - mortality | Survival Analysis | Neuroendocrine Tumors - surgery | Aged | Neuroendocrine Tumors - therapy | Laparotomy | Peritoneal Neoplasms - therapy | Liver cancer | Metastasis | Heart diseases | Health aspects | Coronary heart disease | Analysis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
by Chunkit Fung and Sophie D. Fossa and Michael T. Milano and Jan Oldenburg and Lois B. Travis
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 30, pp. 3807 - 3814
Purpose Increased risks of solid tumors after older radiotherapy strategies for testicular cancer (TC) are well established. Few population-based studies,... 
UNITED-STATES | LUNG-CANCER | LONG-TERM SURVIVORS | HODGKINS-DISEASE | ONCOLOGY | THYROID-CANCER | GERM-CELL TUMORS | CARDIOVASCULAR-DISEASE | RESEARCH STRATEGIES | 2ND MALIGNANT NEOPLASMS | CHILDHOOD-CANCER SURVIVOR | United States - epidemiology | SEER Program | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Kidney Neoplasms - epidemiology | Risk Assessment | Humans | Risk Factors | Thyroid Neoplasms - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasms, Second Primary - mortality | Cisplatin - administration & dosage | Incidence | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Testicular Neoplasms - surgery | Testicular Neoplasms - drug therapy | Cisplatin - adverse effects | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Neoplasms, Germ Cell and Embryonal - surgery | Chemotherapy, Adjuvant | Soft Tissue Neoplasms - epidemiology | Index Medicus | Guc8 | ORIGINAL REPORTS | Epid8
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
by Bockhorn, Maximilian, MD and Uzunoglu, Faik G., MD and Adham, Mustapha, MD and Imrie, Clem, MD and Milicevic, Miroslav, MD and Sandberg, Aken A., MD and Asbun, Horacio J., MD and Bassi, Claudio, MD and Büchler, Markus, MD and Charnley, Richard M., MD and Conlon, Kevin, MD and Cruz, Laureano Fernandez, MD and Dervenis, Christos, MD and Fingerhutt, Abe, MD and Friess, Helmut, MD and Gouma, Dirk J., MD and Hartwig, Werner, MD and Lillemoe, Keith D., MD and Montorsi, Marco, MD and Neoptolemos, John P., MD and Shrikhande, Shailesh V., MD and Takaori, Kyoichi, MD and Traverso, William, MD and Vashist, Yogesh K., MD and Vollmer, Charles, MD and Yeo, Charles J., MD and Izbicki, Jakob R., MD and Int Study Grp Pancreatic Surg and International Study Group of Pancreatic Surgery
Surgery, ISSN 0039-6060, 2014, Volume 155, Issue 6, pp. 977 - 988
Background This position statement was developed to expedite a consensus on definition and treatment for borderline resectable pancreatic ductal adenocarcinoma... 
Surgery | SURGERY | VASCULAR RESECTION | DISTAL PANCREATECTOMY | BODY CANCER | DUCTAL ADENOCARCINOMA | PREOPERATIVE THERAPY | ARTERIAL RESECTION | PORTAL-VEIN RESECTION | SURVIVAL DURATION | CELIAC AXIS RESECTION | MARGIN STATUS | Prognosis | Pancreatectomy - standards | Humans | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Carcinoma, Pancreatic Ductal - therapy | Preoperative Care - standards | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - surgery | Patient Selection | Neoadjuvant Therapy | Neoplasm Staging | Pancreatic Neoplasms - therapy | Preoperative Care - methods | Research | Surgical clinics | Pancreatic cancer | Oncology, Experimental | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
by du Bois, Andreas, Prof and Kristensen, Gunnar, Prof and Ray-Coquard, Isabelle, Prof and Reuss, Alexander, MSc and Pignata, Sandro, MD and Colombo, Nicoletta, Prof and Denison, Ursula, MD and Vergote, Ignace, Prof and del Campo, Jose M, MD and Ottevanger, Petronella, PhD and Heubner, Martin, MD and Minarik, Thomas, PhD and Sevin, Emmanuel, MD and de Gregorio, Nikolaus, MD and Bidziński, Mariusz, Prof and Pfisterer, Jacobus, Prof and Malander, Susanne, MD and Hilpert, Felix, Prof and Mirza, Mansoor R, MD and Scambia, Giovanni, Prof and Meier, Werner, Prof and Nicoletto, Maria O, MD and Bjørge, Line, Prof and Lortholary, Alain, MD and Sailer, Martin Oliver, PhD and Merger, Michael, MD and Harter, Philipp, MD and European Network Gynaecologic Onco and AGO Study Grp Led Gynecologic Canc and AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium and Oncology and Pathology, Kamprad Lab and Lund University and Lunds universitet and Onkologi och Patologi, Kampradlab
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 78 - 89
Summary Background Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor,... 
Hematology, Oncology and Palliative Medicine | BIBF 1120 | DES CANCERS | INTERGROUP TRIAL | LABEL DOSE-ESCALATION | CISPLATIN | ONCOLOGY | BEVACIZUMAB | TRIPLE ANGIOKINASE INHIBITOR | CARBOPLATIN PLUS PACLITAXEL | III TRIAL | MAINTENANCE THERAPY | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Diarrhea - chemically induced | Cytoreduction Surgical Procedures | Indoles - administration & dosage | Young Adult | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Double-Blind Method | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Anemia - chemically induced | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Thrombocytopenia - chemically induced | Disease Progression | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Intention to Treat Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | Clinical trials | Chemotherapy | Hospitals | Growth factors | Cancer | Ovarian cancer | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
by Burger, Robert A and Brady, Mark F and Bookman, Michael A and Fleming, Gini F and Monk, Bradley J and Huang, Helen and Mannel, Robert S and Homesley, Howard D and Fowler, Jeffrey and Greer, Benjamin E and Boente, Matthew and Birrer, Michael J and Liang, Sharon X and Gynecologic Oncology Grp and Gynecologic Oncology Group
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 26, pp. 2473 - 2483
Incorporating bevacizumab in a chemotherapy regimen (7.5 mg/kg every 3 weeks for five or six cycles) and then continuing bevacizumab alone for a total of 12... 
ANTIANGIOGENIC THERAPY | MEDICINE, GENERAL & INTERNAL | ASCITES | SOLID TUMORS | FACTOR EXPRESSION | PHASE-II | MONOCLONAL-ANTIBODY | PROGNOSTIC-SIGNIFICANCE | TUMOR ANGIOGENESIS | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Ovarian Neoplasms - mortality | Bevacizumab | Young Adult | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Carboplatin - administration & dosage | Combined Modality Therapy | Neoplasms, Glandular and Epithelial - surgery | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Quality of Life | Aged | Ovarian Neoplasms - surgery | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Ovarian cancer | Intravenous administration | Body weight | Cancer therapies | Survival | Patients | Angiogenesis | Chemotherapy | Surgery | Paclitaxel | Monoclonal antibodies | Carboplatin | Vascular endothelial growth factor | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
by Shipley, William U and Seiferheld, Wendy and Lukka, Himanshu R and Major, Pierre P and Heney, Niall M and Grignon, David J and Sartor, Oliver and Patel, Maltibehn P and Bahary, Jean-Paul and Zietman, Anthony L and Pisansky, Thomas M and Zeitzer, Kenneth L and Lawton, Colleen A.F and Feng, Felix Y and Lovett, Richard D and Balogh, Alexander G and Souhami, Luis and Rosenthal, Seth A and Kerlin, Kevin J and Dignam, James J and Pugh, Stephanie L and Sandler, Howard M and NRG Oncology RTOG
The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 5, pp. 417 - 428
With a median follow-up of 13 years, a randomized comparison of radiotherapy with or without antiandrogen therapy in patients with a rising PSA level after... 
PHASE-III TRIAL | ANDROGEN DEPRIVATION | MEDICINE, GENERAL & INTERNAL | BICALUTAMIDE 150 MG | MONOTHERAPY | CARDIOVASCULAR MORTALITY | RADIOTHERAPY | RTOG | CASTRATION | CARCINOMA | MEDIAN FOLLOW-UP | Neoplasm Recurrence, Local - radiotherapy | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Radiotherapy - adverse effects | Neoplasm Recurrence, Local - mortality | Incidence | Neoplasm Metastasis | Aged, 80 and over | Prostatic Neoplasms - drug therapy | Gynecomastia - chemically induced | Double-Blind Method | Prostatic Neoplasms - surgery | Kaplan-Meier Estimate | Survival Rate | Combined Modality Therapy | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Tosyl Compounds - therapeutic use | Androgen Antagonists - therapeutic use | Prostatectomy | Aged | Androgen Antagonists - adverse effects | Neoplasm Staging | Nitriles - adverse effects | Nitriles - therapeutic use | Usage | Care and treatment | Cancer patients | Antiandrogens | Radiotherapy | Prostate cancer | Health aspects | Gynecomastia | Tablets | Prostate-specific antigen | Oncology | Death | Radiation therapy | Cancer therapies | Survival | Prostate | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights